Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.32 |
| ▸ | MEN1 | O00255 | 1/20 | 0.32 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.32 |
| ▸ | KDM5A | P29375 | 1/20 | 0.30 |
| ▸ | KDM4C | Q9H3R0 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11905299 | 0.90 | L3MBTL1 (0.31) | L3MBTL1MEN1KMT2A | |
| SCHEMBL11905938 | 0.89 | MEN1 (0.42) | L3MBTL1MEN1KMT2AKDM5AKDM4C | |
| SCHEMBL11905296 | 0.88 | KDM5A (0.30) | KDM5AKDM4C | |
| SCHEMBL11905261 | 0.88 | KDM5A (0.30) | KDM5AKDM4C | |
| SCHEMBL11906203 | 0.88 | KDM5A (0.33) | KDM5AKDM4C | |
| SCHEMBL11905545 | 0.87 | L3MBTL1 (0.30) | L3MBTL1 | |
| SCHEMBL11905230 | 0.87 | L3MBTL1 (0.33) | L3MBTL1 | |
| SCHEMBL11905177 | 0.83 | KDM5A (0.44) | L3MBTL1MEN1KMT2AKDM5AKDM4C | |
| SCHEMBL11905576 | 0.82 | MEN1 (0.49) | MEN1KMT2AKDM5A | |
| SCHEMBL11906258 | 0.81 | KDM5A (0.32) | KDM5AKDM4C |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9567354-B2 | Amino acid-modified silane compounds and making method | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2017-02-14 | — | — | US | disclosed |
| US-20120209020-A1 | AMINO ACID-MODIFIED SILANE COMPOUNDS AND MAKING METHOD | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2012-08-16 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120209020-A1 | AMINO ACID-MODIFIED SILANE COMPOUNDS AND MAKING METHOD | BCAT2, BCAT1, ASNS | L3MBTL1 2402/4885MEN1 1377/4885KMT2A 442/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.